Literature DB >> 2421753

Are blood group isoantigens lost from malignant prostatic epithelium? Immunohistochemical support for the preservation of the H isoantigen.

P Vowden, A D Lowe, E S Lennox, N M Bleehen.   

Abstract

Previous studies while demonstrating the presence of blood group isoantigens on normal prostatic epithelium have failed to identify such antigens on malignant prostatic tissue. Using a series of blood group specific monoclonal antibodies directed towards the A, B, H and Y antigens we have reinvestigated blood group isoantigen expression in both benign prostatic hypertrophy and prostatic adenocarcinoma. Results obtained from areas of benign prostatic hypertrophy are in broad agreement with those published however though we were unable to detect either A or B blood group isoantigens Type 2H and Y isoantigens were identified in 10 of the 12 tumours. These findings, while differing from previously reported results, lend support to the suggested connection between ontogenesis, oncogenesis and blood group isoantigen expression and also support the proposed link between Type 2 structures and malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421753      PMCID: PMC2001367          DOI: 10.1038/bjc.1986.53

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Glycoprotein metabolism in inflammatory and neoplastic diseases of the human colon.

Authors:  Y S Kim; R Isaacs
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

2.  Differentiation of HeLa cells with respect to blood group H antigen.

Authors:  C Pann; W J Kuhns
Journal:  Nat New Biol       Date:  1972-11-01

3.  Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease.

Authors:  J R Wherrett; S I Hakomori
Journal:  J Biol Chem       Date:  1973-05-10       Impact factor: 5.157

4.  Enzymic conversion of "H1-glycolipid" to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma.

Authors:  K Stellner; S Hakomori; G S Warner
Journal:  Biochem Biophys Res Commun       Date:  1973-11-16       Impact factor: 3.575

5.  Monoclonal anti-A and anti-B: development as cost-effective reagents.

Authors:  D Voak; E Lennox; S Sacks; C Milstein; J Darnborough
Journal:  Med Lab Sci       Date:  1982-04

6.  Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract.

Authors:  C M Chapman; E P Allhoff; K H Proppe; G R Prout
Journal:  J Histochem Cytochem       Date:  1983-04       Impact factor: 2.479

7.  Blood group substances as tumor antigens in the distal colon.

Authors:  H S Cooper; W E Haesler
Journal:  Am J Clin Pathol       Date:  1978-06       Impact factor: 2.493

8.  The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.

Authors:  P J Finan; J R Anderson; P T Doyle; E S Lennox; N M Bleehen
Journal:  Br J Urol       Date:  1982-12

9.  THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE. III. THE A, B, AND H ANTIGENS IN EMBRYOS AND FETUSES FROM 18 MM IN LENGTH.

Authors:  A E SZULMAN
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

10.  Immunohistochemical techniques in the early screening of monoclonal antibodies to human colonic epithelium.

Authors:  P J Finan; R M Grant; C de Mattos; F Takei; P J Berry; E S Lennox; N M Bleehen
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

View more
  8 in total

Review 1.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

2.  Semiquantitative immunohistochemical studies of blood group antigen A, B, H, Le(a), Le(b) structures and Ii backbone chains in the normal human cervix and in cervical adenocarcinoma.

Authors:  N R Griffin; M Wells
Journal:  Histochem J       Date:  1993-03

3.  Deletion of antigens of the Lewis a/b blood group family in human prostatic carcinoma.

Authors:  W W Young; S E Mills; M C Lippert; P Ahmed; S K Lau
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

4.  Thyroid blood group isoantigen expression: a parallel with ABH isoantigen expression in the distal colon.

Authors:  P Vowden; A D Lowe; E S Lennox; N M Bleehen
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

5.  Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array.

Authors:  Chao Gao; Yan Liu; Hongtao Zhang; Yibing Zhang; Michiko N Fukuda; Angelina S Palma; Radoslaw P Kozak; Robert A Childs; Motohiro Nonaka; Zhen Li; Don L Siegel; Peter Hanfland; Donna M Peehl; Wengang Chai; Mark I Greene; Ten Feizi
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

6.  Integration of the transcriptome and glycome for identification of glycan cell signatures.

Authors:  Sandra V Bennun; Kevin J Yarema; Michael J Betenbaugh; Frederick J Krambeck
Journal:  PLoS Comput Biol       Date:  2013-01-10       Impact factor: 4.475

7.  A new monoclonal antibody (A46-B/B10) highly specific for the blood group H type 2 epitope: generation, epitope analysis, serological and histological evaluation.

Authors:  U Karsten; G Pilgrim; F G Hanisch; G Uhlenbruck; M Kasper; P Stosiek; G Papsdorf; G Pasternak
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

8.  The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium.

Authors:  P Vowden; A D Lowe; E S Lennox; N M Bleehen
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.